University Health Network, The Princess Margaret
Welcome,         Profile    Billing    Logout  
 28 Trials 
34 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Fyles, Anthony
NCT00188539: Cervix:Hypoxia, Interstitial Fluid Pressure and GSH Levels

Active, not recruiting
2
300
Canada
Pre-treatment tumour oxygen measurements (under anesthesia)
University Health Network, Toronto, Canadian Cancer Trials Group, Princess Margaret Hospital, Canada
Cervix Neoplasms
12/24
12/24
NCT01181375: Predictive Assays In Cervix Cancer

Active, not recruiting
N/A
500
Canada
Tumour Biopsies and Blood Sampling
University Health Network, Toronto
Cervical Cancer
08/24
08/24
Milosevic, Michael
NCT00160979: Transrectal Tumour Oxygen - US Army

Completed
2
195
Canada
Pre-treatment tumour oxygen measurements
University Health Network, Toronto, U.S. Army Medical Research and Development Command, Princess Margaret Hospital, Canada
Prostatic Neoplasms
02/23
02/23
NCT00188708: Effect of Casodex on Tumour Hypoxia - Prostate Cancer

Completed
N/A
30
Canada
hypoxia measurement
University Health Network, Toronto, Canadian Cancer Trials Group, Princess Margaret Hospital, Canada
Prostatic Neoplasms
03/22
03/22
MRgRT, NCT02701712: Receiving Radiation Therapy in the Research Facility

Recruiting
N/A
150
Canada
Magnetic resonance - guided radiation therapy (MRgRT)
University Health Network, Toronto
Solid Tumors and Metastatic Lesions
02/25
02/25
NCT01549730: Cervix Hypoxia FAZA

Active, not recruiting
N/A
30
Canada
18F-Fluoroazomycin Arabinoside (18F-FAZA)
University Health Network, Toronto
Cervix Cancer
05/26
05/26
NCT01567800: Prostate Hypoxia FAZA

Recruiting
N/A
20
Canada
18F-Fluoroazomycin Arabinoside (18F-FAZA)
University Health Network, Toronto
Prostate Cancer
06/24
03/25
NCT01181375: Predictive Assays In Cervix Cancer

Active, not recruiting
N/A
500
Canada
Tumour Biopsies and Blood Sampling
University Health Network, Toronto
Cervical Cancer
08/24
08/24
VAR-2023-07, NCT06576908: Evaluation of On-Couch CBCT Image Quality

Recruiting
N/A
46
Canada
HyperSight Imaging
Varian, a Siemens Healthineers Company
Head and Neck Cancer, Thoracic Cancer, Abdominal Cancer, Pelvic Cancer
10/25
12/25
MRL1, NCT04135794: Magnetic Resonance-Guided Adaptive Radiotherapy (MRgART) Using an Integrated Magnetic Resonance Linear Accelerator (MRL)

Recruiting
N/A
500
Canada
University Health Network, Toronto
Cancer
11/26
11/26
HPVDNA02, NCT03853915: FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)

Recruiting
N/A
64
Canada
[18-F]- FDG - PET
University Health Network, Toronto, Sunnybrook Health Sciences Centre
Cervical Cancer
12/26
12/26
NCT00957450: Intra-Pelvic Organ Motion for Cervix Cancer Patient Using Imaging

Active, not recruiting
N/A
20
Canada
University Health Network, Toronto
Cervix Cancer
02/26
02/26
Ménard, Cynthia
NCT00791115: Salvage Prostatectomy After Radiotherapy

Completed
N/A
16
Canada
whole-mount sectioning of the prostate
University Health Network, Toronto
Prostate Cancer
05/23
05/23
TOBAS, NCT02098252: Treatment of Brain AVMs () Study

Recruiting
N/A
1000
Europe, Canada, US, RoW
Neurosurgery, Radiation therapy, Embolization
Centre hospitalier de l'Université de Montréal (CHUM), Centre Hospitalier Régional et Universitaire de Brest
Unruptured Brain Arteriovenous Malformation, Ruptured Brain Arteriovenous Malformation, Arteriovenous Malformations, AVM, BAVM
01/35
01/36
Chung, Peter
NCT05916339: AWARE: Management of ADHD in Autism Spectrum Disorder

Recruiting
4
500
Canada, US
Randomization to either Amphetamine (AMP) class of stimulant medication or Methylphenidate (MPH) class of stimulant medication, Randomization to either Alpha 2 agonist class of medication or alternate class of stimulant.
Daniel Coury, Patient-Centered Outcomes Research Institute, University of California, Irvine, Holland Bloorview Kids Rehabilitation Hospital, Children's Hospital of Philadelphia, University of Rochester Golisano Children's Hospital, Nationwide Children's Hospital, Children's Hospital Medical Center, Cincinnati, University of Pittsburgh, Children's Hospital Los Angeles, University of Virginia, University of Alberta, Massachusetts General Hospital, MaineHealth, University of Michigan
ADHD, Autism Spectrum Disorder
01/27
12/27
NCT02565498: Preoperative vs Postoperative IMRT for Extremity/Truncal STS

Active, not recruiting
3
210
Europe, Canada, US
Preoperative intensity modulated radiation therapy, Postoperative intensity modulated radiation therapy
Mount Sinai Hospital, Canada, Princess Margaret Hospital, Canada
Adult Soft Tissue Sarcoma
10/24
05/29
PREDICT-RT, NCT04513717: Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The Trial

Recruiting
3
2478
Canada, US
Apalutamide, ARN 509, ARN-509, ARN509, Erleada, JNJ 56021927, JNJ-56021927, Bicalutamide, Casodex, Cosudex, ICI 176,334, ICI 176334, Buserelin, 6-[O-(1,1-Dimethylethyl)-D-serine]-9-(N-ethyl-L-prolinamide)-10-deglycinamide-luteinizing Hormone-releasing Factor (Pig), BSRL, Busereline, Etilamide, HOE 766, ICI 123215, S74-6766, Degarelix, FE200486, Firmagon, Flutamide, 4'-Nitro-3'-trifluoromethylisobutyranilide, Apimid, Cebatrol, Chimax, Cytomid, Drogenil, Euflex, Eulexine, Flucinom, Flucinome, Flugerel, Fluken, Flulem, FLUT, Fluta-Gry, Flutabene, Flutacan, Flutamex, Flutamin, Flutan, Flutaplex, Fugerel, Grisetin, Niftolide, Oncosal, Profamid, Propanamide, 2-Methyl-N-(4-nitro-3-(trifluoromethyl)phenyl)-, Prostacur, Prostadirex, Prostica, Prostogenat, Sch 13521, Tafenil, Tecnoflut, Testotard, Goserelin, ICI-118630, Histrelin, Leuprolide, Leuprorelin, Quality-of-Life Assessment, Quality of Life Assessment, Questionnaire Administration, Radiation Therapy, Cancer Radiotherapy, ENERGY_TYPE, Irradiate, Irradiated, Irradiation, Radiation, Radiation Therapy, NOS, Radiotherapeutics, Radiotherapy, RT, Therapy, Radiation, Triptorelin, 6-D-Tryptophan-LH-RH, 6-D-Tryptophanluteinizing Hormone-releasing Factor, AY-25650, CL-118,532, Detryptoreline
NRG Oncology, National Cancer Institute (NCI)
Metastatic Malignant Neoplasm in the Bone, Prostate Adenocarcinoma, Stage III Prostate Cancer AJCC v8, Stage IIIA Prostate Cancer AJCC v8, Stage IIIB Prostate Cancer AJCC v8, Stage IIIC Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8
12/33
12/33
NRG-GU013, NCT05946213: Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients With High Risk Prostate Cancer

Recruiting
3
1209
Canada, US
External Beam Radiation Therapy, Definitive Radiation Therapy, EBRT, External Beam Radiation, External Beam Radiotherapy, External Beam Radiotherapy (conventional), External Beam RT, external radiation, External Radiation Therapy, external-beam radiation, Radiation, External Beam, Teleradiotherapy, Teletherapy, Teletherapy Radiation, Stereotactic Body Radiation Therapy, SABR, SBRT, Stereotactic Ablative Body Radiation Therapy
NRG Oncology, National Cancer Institute (NCI)
Stage III Prostate Cancer AJCC v8, Stage IVA Prostate Cancer AJCC v8
03/36
03/41
CONSORT-PC, NCT05656794: Consolidative Prostate Radiotherapy in Metastatic Prostate Cancer

Recruiting
2
40
Canada
Radiotherapy
University Health Network, Toronto
Prostate Metastases
08/31
08/31
NCT03142802: Low-Dose CT - Stage I Testicular Cancer

Active, not recruiting
N/A
251
Canada
Low-dose computed tomography (LDCT)
University Health Network, Toronto
Testicular Cancer
10/11
09/25
FLIP, NCT00789607: Fiducial Localization and Individualized Radiotherapy -Prostate Cancer

Completed
N/A
17
Canada
Transrectal APT Device or Transperineal Device will be used, TRUS probe
University Health Network, Toronto, Princess Margaret Hospital, Canada
Prostate Cancer
06/17
05/23
NCT00890006: Advanced Imaging for Radiotherapy Treatment Planning and Guidance for Low-Intermediate Risk Prostate Cancer (Margin)

Active, not recruiting
N/A
99
Canada
Advanced imaging for radiotherapy planning and guidance
University Health Network, Toronto, Princess Margaret Hospital, Canada
Low or Intermediate Risk Prostate Cancer
09/24
09/24
NCT05041504: A Web-based Peer Navigation Program for Men With Prostate Cancer

Active, not recruiting
N/A
184
Canada
Peer navigation, True North Peer Navigation, Active wait list control, Web-based educational wait list control
University Health Network, Toronto, University of British Columbia, Dalhousie University, University of Toronto, Canadian Cancer Society (CCS), Canadian Partnership Against Cancer, Movember Foundation, Walnut Foundation, Prostate Cancer Support - Toronto, Prostate Cancer Group - Burnaby
Prostate Cancer
03/24
12/24
NCT01802242: Tumor TARGET Prostate Cancer

Active, not recruiting
N/A
85
Canada
Volumetric Modulated Arc Therapy (VMAT) and High-Dose Rate (HDR) Radiotherapy, No Active Treatment - completed Prior Radiation
University Health Network, Toronto, Princess Margaret Hospital, Canada
Prostate Cancer
05/25
05/25
ARTGU, NCT03909893: A Study of Adaptive Radiation Therapy for Pelvic Genitourinary Cancer

Withdrawn
N/A
40
Canada
Adaptive Radiation Therapy
University Health Network, Toronto
Prostate Cancer, Bladder Cancer
01/25
01/25
NCT00913939: High-Dose-Rate Brachytherapy

Recruiting
N/A
400
Canada
MRI Guided Needles to deliver HDR Brachytherapy
University Health Network, Toronto, Princess Margaret Hospital, Canada
Patients With Prostate Cancer
05/25
05/25
PLATON, NCT03784755: Local Ablative Therapy For Hormone Sensitive Oligometastatic Prostate Cancer

Recruiting
N/A
410
Canada
Ablative Radiation Therapy, SBRT, Stereotactic External Beam Irradiation, Stereotactic Radiation Therapy, Stereotactic Radiotherapy, Standard of care
Canadian Cancer Trials Group, Canadian Cancer Society (CCS)
Prostate Cancer Metastatic
12/26
07/27
MRL-Boost, NCT05364229: MR-guided Tumour Boost

Recruiting
N/A
40
Canada
MR-guided Radiotherapy Boost
University Health Network, Toronto
Prostate Cancer
06/30
06/30
Han, Kathy
RHEAL, NCT04228991: Hypofractionated LocoRegional Radiotherapy in Breast Cancer

Recruiting
3
588
Canada
Locoregional radiation treatment - Conventional fractionation, Locoregional radiation treatment - Hypofractionation
Ontario Clinical Oncology Group (OCOG)
Breast Neoplasms, Radiotherapy, Lymphedema
09/25
12/30
RAINBO, NCT05255653: Refining Adjuvant Treatment in Endometrial Cancer Based on Molecular Features

Recruiting
2/3
1615
Europe, Canada
Olaparib, Lynparza, Pelvic external beam radiotherapy, EBRT, Chemotherapy, Cisplatin, Carboplatin, Paclitaxel, Durvalumab, Imfinzi, Medroxyprogesterone Acetate, Progestogen, Megestrol Acetate, Vaginal brachytherapy, Observation
Leiden University Medical Center, Institute Gustave Roussy (sponsor p53abn-RED trial), Leiden University Medical center (sponsor MMRd-GREEN trial), University College London (sponsor NSMP-ORANGE trial), Canadian Clinical Trials Group (sponsor POLEmut-BLUE trial), Dutch Gynaecological Oncology Group, Comprehensive Cancer Centre The Netherlands, Cancer Research UK & UCL Cancer Trials Centre, Dutch Cancer Society, AstraZeneca, National Cancer Institute, France, Canadian Institutes of Health Research (CIHR)
Endometrial Cancer
01/30
01/31
SPARTACUSII, NCT04890912: Stereotactic Pelvic Adjuvant Radiation Therapy in Cancers of the Uterus II

Recruiting
2
50
Canada
Conventional Fractionation, Hypofractionation
Sunnybrook Health Sciences Centre, Princess Margaret Hospital, Canada, Royal Victoria Hospital, Canada, Credit Valley Hospital, London Regional Cancer Program, Canada
Endometrial Cancer
06/22
06/23
CCTG EN10, NCT05640999: Adjuvant Therapy in POLE-Mutated and p53-Wildtype/NSMP Early Stage Endometrial Cancer RAINBO BLUE & TAPER

Recruiting
2
325
Europe, Canada, US, RoW
Vaginal brachytherapy, Adjuvant radiotherapy (EBRT +/- brachytherapy), Observation
Canadian Cancer Trials Group, Canadian Cancer Clinical Trials Network
Endometrial Cancer
12/28
06/29
HPVDNA02, NCT03853915: FDG-PET and Circulating HPV in Patients With Cervical Cancer Treated With Definitive Chemoradiation (II)

Recruiting
N/A
64
Canada
[18-F]- FDG - PET
University Health Network, Toronto, Sunnybrook Health Sciences Centre
Cervical Cancer
12/26
12/26
LANDMARC, NCT04665388: LANDscape MApping of Epitopes and T Cell Receptors for Selected Cancers

Recruiting
N/A
105
Canada
University Health Network, Toronto
Solid Tumor
02/26
02/26
Elantholiparameswaran, Saibishkumar
No trials found

Download Options